Y.B Urban Renewal - Residential Development Ltd (TASE: YBRD)
Health Care · Pharmaceuticals · IL
₪5.96
-0.43% today · -19.4% 1Y
Y.B Urban Renewal - Residential Development Ltd (TASE: YBRD) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $9.53M.
Over the last twelve months the share price has lost 19.4%, trading between 5.50 and 8.99.
Tweenvest scores Y.B Urban Renewal - Residential Development Ltd across four factors: quality 31/100. Its strongest factor is quality.
YBRD price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $9.53M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.79
- Dividend yield
- —
- Beta (5Y)
- 0.27
- 52-week high
- ₪8.99
- 52-week low
- ₪5.50
- Avg volume (3M)
- —
- Shares outstanding
- 4.76M
- Employees
- —
- Next earnings
- —
About Y.B Urban Renewal - Residential Development Ltd
Cannassure Therapeutics Ltd cultivates and produces medical cannabis. Its products comprise medical cannabis oils, indoor inflorescences, select inflorescences, value inflorescences, and cannavix. The company was founded in 2016 and is based in Ashdod, Israel.
- ISIN
- IL0001110134
- Founded
- 2016
- Listed since
- Jan 16, 2019
- Exchange
- The Tel-Aviv Stock Exchange
- Currency
- ILS
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $368.80B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.